CAR-T therapy is a potent cellular immune treatment that genetically trains an individual’s immune system to both recognize and attack cancerous cells.

It is critical to be aware of the signs and symptoms that may indicate there is a need to begin treatment.

A variety of tests are used to capture images inside the body when chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are present.

Integrative medicine is a patient-centered, evidence-informed field of comprehensive cancer care to promote optimal health and well-being.

Tumor lysis syndrome is a rare condition that can happen due to the rapid death of cancer cells.

Autoimmune hemolytic anemia (AIHA) is the most common autoimmune condition associated with CLL and SLL.

Immune thrombocytopenic purpura (ITP) is a rare but serious complication that happens in an estimated 1-5% of those living with CLL and SLL.

Measurable residual disease (MRD) testing measures the amount of cancer cells that are present in blood or bone marrow at the time the sample was collected.

MBL is a condition where there is an accumulation of abnormal B-cells in the blood.